Alkermes (NASDAQ: ALKS) net income
Alkermes reported a net profit of $241.7m for fiscal 2025, 34.2% less than in fiscal 2024 ($367.1m). Its net margin was 16.4%. Earnings per share were $1.47.
Alkermes's best year of the last 10 was fiscal 2024. The biggest drop was in fiscal 2025, −34.2%. It reported a loss in 7 of those 10 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | $241.7m | −34.2% | 16.4% | $1.47 |
| 2024 | $367.1m | +3.2% | 23.6% | $2.22 |
| 2023 | $355.8m | — | 21.4% | $2.14 |
| 2022 | −$158.3m | — | −14.2% | −$0.97 |
| 2021 | −$48.2m | — | −4.1% | −$0.30 |
| 2020 | −$110.9m | — | −10.7% | −$0.70 |
| 2019 | −$196.6m | — | −16.8% | — |
| 2018 | −$139.3m | — | −12.7% | — |
| 2017 | −$157.9m | — | −17.5% | — |
| 2016 | −$208.4m | — | −28.0% | — |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
Alkermes net income compared with its sector
By net income for its latest fiscal year, Alkermes ranks 81st of the 501 US health care companies with a page on Celsmar. The sector median net margin is −6.2%; that of Alkermes, 16.4%.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 79th | BioCryst Pharmaceuticals | $263.9m | 30.2% |
| 80th | Insulet | $247.1m | 9.1% |
| 81st | Alkermes | $241.7m | 16.4% |
| 82nd | Revvity | $241.2m | 8.4% |
| 83rd | Lantheus | $233.6m | 15.2% |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of Alkermes
- How much did Alkermes earn in fiscal 2025?
- Alkermes reported a net profit of $241.7m for fiscal 2025. In fiscal 2024 it reported a net profit of $367.1m.
- What are the earnings per share of Alkermes?
- They were $1.47 in fiscal 2025, compared with $2.22 in fiscal 2024.
- What is the net margin of Alkermes?
- In fiscal 2025 its net profit was 16.4% of its revenue.
- What was the most profitable year for Alkermes?
- Of its last 10 fiscal years, fiscal 2024, with $367.1m.
- Where does Alkermes rank in its sector by net income?
- It ranks 81st of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for Alkermes come from?
- From the annual report (Form 10-K) that Alkermes files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that Alkermes files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023 · 2022 · 2021 · 2020 · 2019 · 2018 · 2017 · 2016. More on Alkermes: the Alkermes page · annual accounts · revenue · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.